Search research articles
Contact Us
Filters
Showing results (111-120 of 122) with videos related to
Page
of 13
Sort By:
Science Advances
|
April 9, 2025
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease
Taihua Yang, Jiahao Ge, Lei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery
Haifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Trends in Cancer
|
November 10, 2020
Education and Outreach in Physical Sciences in Oncology
Sierra A Walker, Anthony Pham, Sara Nizzero, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2014
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
Bhuvanesh Dave, Sergio Granados-Principal, Rui Zhu, et al.
Science Advances
|
October 11, 2024
Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity
Ting Fan, Congcong Xu, Jichuan Wu, et al.
Eclinicalmedicine
|
January 3, 2024
Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)
Yi Fang, Jing-Xin Li, Davone Duangdany, et al.
Nature
|
March 28, 2014
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
Xi Chen, Dimitrios Iliopoulos, Qing Zhang, et al.
Blood
|
February 26, 2015
Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia
Saradhi Mallampati, Xiaohong Leng, Haiqing Ma, et al.
Ebiomedicine
|
April 26, 2023
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial
Yu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, et al.
The Journal of Clinical Investigation
|
March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Eugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Page
of 13
Search research articles
Search
Showing results (111-120 of 122) with videos related to
Sort By:
Page
of 13
Science Advances
|
April 9, 2025
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease
Taihua Yang, Jiahao Ge, Lei Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector delivery
Haifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Trends in Cancer
|
November 10, 2020
Education and Outreach in Physical Sciences in Oncology
Sierra A Walker, Anthony Pham, Sara Nizzero, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2014
Targeting RPL39 and MLF2 reduces tumor initiation and metastasis in breast cancer by inhibiting nitric oxide synthase signaling
Bhuvanesh Dave, Sergio Granados-Principal, Rui Zhu, et al.
Science Advances
|
October 11, 2024
Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity
Ting Fan, Congcong Xu, Jichuan Wu, et al.
Eclinicalmedicine
|
January 3, 2024
Safety, immunogenicity, and efficacy of a modified COVID-19 mRNA vaccine, SW-BIC-213, in healthy people aged 18 years and above: a phase 3 double-blinded, randomized, parallel controlled clinical trial in Lao PDR (Laos)
Yi Fang, Jing-Xin Li, Davone Duangdany, et al.
Nature
|
March 28, 2014
XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway
Xi Chen, Dimitrios Iliopoulos, Qing Zhang, et al.
Blood
|
February 26, 2015
Tyrosine kinase inhibitors induce mesenchymal stem cell-mediated resistance in BCR-ABL+ acute lymphoblastic leukemia
Saradhi Mallampati, Xiaohong Leng, Haiqing Ma, et al.
Ebiomedicine
|
April 26, 2023
Safety and immunogenicity of a modified COVID-19 mRNA vaccine, SW-BIC-213, as a heterologous booster in healthy adults: an open-labeled, two-centered and multi-arm randomised, phase 1 trial
Yu-Zhou Gui, Xue-Ning Li, Jing-Xin Li, et al.
The Journal of Clinical Investigation
|
March 12, 2014
Transport properties of pancreatic cancer describe gemcitabine delivery and response
Eugene J Koay, Mark J Truty, Vittorio Cristini, et al.
Page
of 13